Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21

CI Caescu, X Guo, L Tesfa, TD Bhagat… - Blood, The Journal …, 2015 - ashpublications.org
Macrophage polarization between the M2 (repair, protumorigenic) and M1 (inflammatory)
phenotypes is seen as a continuum of states. The detailed transcriptional events and signals …

[HTML][HTML] Epigenetic silencing of miR-145-5p contributes to brain metastasis

S Donzelli, F Mori, T Bellissimo, A Sacconi, B Casini… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Brain metastasis is a major cause of morbidity and mortality of lung cancer patients. We
assessed whether aberrant expression of specific microRNAs could contribute to brain …

EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer

M Kedmi, N Ben-Chetrit, C Körner, M Mancini… - Science …, 2015 - science.org
Growth factors promote tumor growth and metastasis. We found that epidermal growth factor
(EGF) induced a set of 22 microRNAs (miRNAs) before promoting the migration of mammary …

[HTML][HTML] MicroRNAs and growth factors: an alliance propelling tumor progression

M Kedmi, A Sas-Chen, Y Yarden - Journal of Clinical Medicine, 2015 - mdpi.com
Tumor progression requires cancer cell proliferation, migration, invasion, and attraction of
blood and lymph vessels. These processes are tightly regulated by growth factors and their …

[HTML][HTML] Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers

Q Zhao, J Cao, YC Wu, X Liu, J Han… - American Journal of …, 2015 - ncbi.nlm.nih.gov
Abstract miRNA expression is deregulated in non-small cell lung cancer (NSCLC), and
some miRNAs are associated with gefitinib sensitivity. Here, we investigated if circulating …

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways

SM Rothenberg, K Concannon, S Cullen, G Boulay… - Elife, 2015 - elifesciences.org
Treatment of EGFR-mutant lung cancer with erlotinib results in dramatic tumor regression
but it is invariably followed by drug resistance. In characterizing early transcriptional …

Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression

H Cohen‐Dvashi, N Ben‐Chetrit, R Russell… - EMBO molecular …, 2015 - embopress.org
Dissemination of primary tumor cells depends on migratory and invasive attributes. Here, we
identify Navigator‐3 (NAV 3), a gene frequently mutated or deleted in human tumors, as a …

RNA-mediated degradation of microRNAs: A widespread viral strategy?

J McCaskill, P Praihirunkit, PM Sharp, AH Buck - RNA biology, 2015 - Taylor & Francis
Regulation of small RNAs by other non-coding RNAs is a ubiquitous feature of gene
regulatory systems that can be exploited by viruses. Examples of this have been described …

[HTML][HTML] Transcriptional dynamics reveal critical roles for non-coding RNAs in the immediate-early response

S Aitken, S Magi, AMN Alhendi, M Itoh… - PLoS computational …, 2015 - journals.plos.org
The immediate-early response mediates cell fate in response to a variety of extracellular
stimuli and is dysregulated in many cancers. However, the specificity of the response across …

[HTML][HTML] Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to …

AL Teixeira, F Dias, M Ferreira, M Gomes, JI Santos… - PLoS …, 2015 - journals.plos.org
The epidermal growth factor (EGF) is responsible for the activation of intracellular signal
transducers that act on cell-cycle progression, cell motility, angiogenesis and inhibition of …